Prevalence of delta antigen/antibody in B-viral-associated hepatocellular carcinoma
- 15 April 1984
- Vol. 53 (8), 1692-1694
- https://doi.org/10.1002/1097-0142(19840415)53:8<1692::aid-cncr2820530812>3.0.co;2-5
Abstract
Sera from 39 patients with B-viral associated hepatocellular carcinoma were studied for the presence of delta antibody using solid-phase blocking radioimmunoassay. Only one patient (2.5%) had circulating delta antibody in the serum, and stainable delta antigen in the nuclei of the nontumor liver. A similar study of the sera of 57 patients with chronic B-viral disease without hepatocellular carcinoma revealed 18 patients (31.5%) with delta antibody. This significant difference (P > 0.001) in the prevalence of delta antibody among these two groups is probably related to the epidemiologic background, reflected as a racial difference.This publication has 14 references indexed in Scilit:
- MULTICENTRE STUDY OF PREVALENCE OF HBV-ASSOCIATED DELTA INFECTION AND LIVER DISEASE IN DRUG-ADDICTSThe Lancet, 1982
- Infection with the Delta (δ) Agent in Chronic HBsAg CarriersGastroenterology, 1981
- HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUSThe Lancet, 1981
- Clinical features of hepatocellular carcinoma: Review of 211 patients in Hong KongCancer, 1981
- Identification of integrated hepatitis B virus DNA sequences in human hepatocellular carcinomasHepatology, 1981
- EPIDEMIOLOGY OF HBV-ASSOCIATED DELTA AGENT: GEOGRAPHICAL DISTRIBUTION OF ANTI-DELTA AND PREVALENCE IN POLYTRANSFUSED HBsAg CARRIERSThe Lancet, 1980
- INCIDENCE AND SIGNIFICANCE OF ANTIBODIES TO DELTA ANTIGEN IN HEPATITIS B VIRUS INFECTIONThe Lancet, 1979
- Liver cell dysplasia.Association with hepatocellular carcinoma, cirrhosis and hepatitis B antigen carrier statusCancer, 1979
- Hepatocellular carcinoma in the U.S.A., etiologic considerationsGastroenterology, 1979
- Hepatitis-Associated Antigen and Hepatocellular Carcinoma in TaiwanAnnals of Internal Medicine, 1971